QPBE
XBI icon

Quintet Private Bank (Europe)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Quintet Private Bank (Europe)’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-266
Closed -$24K – 219
2024
Q4 		$24K Sell
266
-134
-34% -$13K ﹤0.01% 169
2024
Q3 		$39.5K Buy
+400
New +$39.3K ﹤0.01% 153

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Quintet Private Bank (Europe)'s XBI Position: Q1 2025 in Review

Quintet Private Bank (Europe) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 266 shares — an estimated $24K sold.

Quintet Private Bank (Europe) first reported a position in XBI in Q3 2024 and held it in 2 quarters. The position peaked at $39.5K in Q3 2024. 683 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

  • Quintet Private Bank (Europe) reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
  • Quintet Private Bank (Europe) sold 266 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $24K.
  • Quintet Private Bank (Europe) first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and held it in 2 quarters.
  • Quintet Private Bank (Europe)'s State Street SPDR S&P Biotech ETF position peaked at $39.5K in Q3 2024.
  • 683 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Quintet Private Bank (Europe)'s 13F filing for Q1 2025, filed 16 Apr 2025.